Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App

Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days. The post Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App appeared first…

Read More

Diabetes Eradication? The New Chronic Condition Care Playbook and How GLP-1s Are Changing the Game

GLP-1 medications are transforming how we think about chronic disease management and, more importantly, prevention. Ongoing research has found them to be effective in the prevention or treatment of diabetes, heart attacks and strokes, kidney disease, liver disease, sleep apnea, and more. The post Diabetes Eradication? The New Chronic Condition Care Playbook and How GLP-1s…

Read More

Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients

By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used — not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health. The post Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients appeared first on MedCity…

Read More